Stocks · News reference

REGENXBIO shares are trading lower after the company announced the pricing of its offering of 10,003,889 shares at $9.00 per share and 1,111,111 pre-funded warrants at $8.9999 per warrant.

Jul 17, 2026, 12:47 PMBenzinga Newsdesk

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

SEC EDGARAug 25, 2026, 8:57 PMSEC EDGAR
8-K filing — REGENXBIO Inc. (RGNX)
Filed: 2026-08-25 AccNo: 0001193125-26-365287 Size: 203 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
Read original at edgar
RGNX
BenzingaAug 25, 2026, 3:31 PMBenzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Regenxbio, Lowers Price Target to $21
HC Wainwright & Co. analyst Yi Chen maintains Regenxbio (NASDAQ:RGNX) with a Buy and lowers the price target from $23 to $21.
Read original at benzinga
RGNX
BenzingaAug 25, 2026, 10:29 AMBenzinga Newsdesk
Baird Maintains Outperform on Regenxbio, Lowers Price Target to $29
Baird analyst Brian Skorney maintains Regenxbio (NASDAQ:RGNX) with a Outperform and lowers the price target from $32 to $29.
Read original at benzinga
RGNX
BenzingaAug 24, 2026, 4:03 PMAvi Kapoor
Crude Oil Down 3%; XPeng Shares Fall After Q2 Results
US stocks traded mixed with the Dow Jones index gaining over 150 points. Consumer staples shares jumped while information technology stocks fell. XPeng Inc shares fell 7% due to wider than expected loss and lower revenue outlook.
Read original at benzinga
AAOI ALVO AZTA NSSC RGNX